Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Invest Like Warren Buffett With These ETFs

Published 02/20/2018, 03:11 AM
Updated 07/09/2023, 06:31 AM

Following investing strategies of billionaire investor Warren Buffett is everyone’s dream. Buffett’s Berkshire Hathaway Inc. (NYSE:BRKa) BRK.B has added more than 100% over the last five years (as of February 15, 2018), way better than the 73% gain of the broader market ETF SPDR S&P 500 ETF (NYSE:SPY) (AX:SPY) during the same time frame.

The winning trend of Berkshire Hathaway is continuing as the entity tacked on about 12% in the last three months compared with 5.6% offered by the key U.S. equity gauge S&P 500 index-based ETF.

Notably, Berkshire Hathaway's 13F filing disclosing the fourth-quarter stock holdings has shown some major changes. Below we highlight those alterations in portfolios, so that retail investors can bank on some winning ETF and stock investment strategies.

Take a Bite of Apple (NASDAQ:AAPL)

Buffett is outright bullish on Apple. This is evident from his raising of stake in Apple by 23.3% to 165.3 million shares. Last year, Buffett indicated that consumers ‘want the product’ (or Apple products) despite its price. The in-fashion stock gained more than 9% in the last five days (as of Feb 15, 2018), mostly reflecting Berkshire Hathaway’s interests. Apple’s five-day gains of 6.3% came in comparison of 3.5% increase in SPY (as of Feb 16, 2018).

Apple has a Value Score of B. Investors interested in following Buffett and being part of Apple’s growth story, can play ETFs like iShares Dow Jones US Technology ETF IYW, Select Sector SPDR Technology ETF XLK and Vanguard Information Technology ETF (HN:VGT) (read: Can Tech ETFs Regain Investors' Love After Selloff Snub?).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Rush Out of IBM (NYSE:IBM)

Berkshire scrapped about 94.5% of its IBM holdings, leaving only 2.05 million shares. In his latest move, Buffett cut IBM holdings by about 32%. Per an article published on CNBC, Buffett last year said "IBM is a big strong company, but they've got big strong competitors too."

So, investors following Buffett may opt to stay away from the likes of First Trust NASDAQ Technology Dividend Index Fund TDIV as the fund has about 8% weight in IBM. But the fund has other strong candidates like Apple (read: ETFs to Buy as Cisco Returns to Revenue Growth in 2 Years).

Treat Teva Nicely

Berkshire surprised many investors by disclosing its stake in drug-maker Teva Pharmaceutical Industries Limited (NYSE:TEVA) during the fourth quarter. Teva has about 15.7% weight in iShares MSCI Israel ETF EIS, around 5% weight in VanEck Vectors Pharmaceutical ETF (AX:PPH) and 5.4% in VanEck Vectors Generic Drugs ETF GNRX.

Bet Big on Bank of New York Mellon (NYSE:BK)

Berkshire upped its stake in Bank of New York Mellon (BK) by about 20% during the fourth quarter. The stock has about 4.6% exposure in Davis Select Financial ETF DFNL.

Get Rid of General Mortars

Berkshire offloaded 10 million shares of General Motors (NYSE:GM) , which lowered its holdings by 16%. Funds like First Trust Nasdaq Transportation ETF FTXR and First Trust NASDAQ Global Auto Index Fund CARZ have around 7% focus in General Motors.

Want key ETF info delivered straight to your inbox?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



General Motors Company (GM): Free Stock Analysis Report

SPDR-TECH SELS (XLK): ETF Research Reports

SPDR-SP 500 TR (SPY): ETF Research Reports

FT-NDQ TECH DIF (TDIV): ETF Research Reports

VIPERS-INFO TEC (VGT): ETF Research Reports

VANECK-GEN DRG (GNRX): ETF Research Reports

ISHARS-US TECH (IYW): ETF Research Reports

FT-NDQ GL AUTO (CARZ): ETF Research Reports

VANECK-PHARMA (PPH): ETF Research Reports

ISHRS-MSCI ISRL (EIS): ETF Research Reports

Berkshire Hathaway Inc. (BRK.B): Free Stock Analysis Report

Teva Pharmaceutical Industries Ltd. (TEVA): Free Stock Analysis Report

FT-NDQ TRANSPRT (FTXR): ETF Research Reports

DAVIS-SEL FINL (DFNL): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.